MetLife, Inc.
$54.29B- Market cap
- $61.50B
- Debt
- +$14.82B
- Cash
- −$22.03B
Capital structure 81% equity / 19% debt · EV / Revenue 0.70x · EV proxy / EBITDA proxy 8.57x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt cap
Decision snapshot: MET stock price at discount vs WMT $96.78 current versus $192.21 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WMT's multiple
Implied fair value · at MET's multiple
Close Dec 31, 2025
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Multiple discount
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 81% equity / 19% debt · EV / Revenue 0.70x · EV proxy / EBITDA proxy 8.57x
Capital structure 95% equity / 5% debt · EV / Revenue 1.29x
WMT carries the larger enterprise value at $917.93B against $54.29B; MET trades on the lower EV / Revenue multiple (0.70x vs 1.29x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MetLife, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
WALMART INC. · implied price per share
Bear
$26.01
Base
$31.42
Bull
$38.87
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AFLAC INC
MET vs AFL
American International Group, Inc.
MET vs AIG
LINCOLN NATIONAL CORP
MET vs LNC
HARTFORD FINANCIAL SERVICES GROUP, INC.
MET vs HIG
TARGET CORP
MET vs TGT
Costco Wholesale Corporation
MET vs COST
Amazon.com, Inc.
MET vs AMZN
CVS Health Corporation
MET vs CVS
Walgreens Boots Alliance, Inc.
MET vs WBA
DOLLAR GENERAL CORP
MET vs DG
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.